Finished
Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal Cancer
NCT04572100 · University of Chicago · Updated 7 July 2023
- What is being tested
- Transoral Robotic Surgery (TORS) or Radiotherapy; Chemotherapy and Low-Dose Radiotherapy; Chemotherapy and High-Dose Radiotherapy; Paclitaxel; Carboplatin
- For
- Oropharyngeal Squamous Cell Carcinoma
- Kind of study
- Tests a treatment or device on volunteers. Phase 1.
- Who can join
- Ages 18 years and older. About 50 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 1 Oct 2020, ends 9 Jan 2023. Registered 1 Oct 2020.
- Results
- None posted yet.
In the researchers' words
Doctors leading this study will give blood tests to head and neck cancer participants during the beginning of chemotherapy treatment (also known as induction therapy) to see if these blood tests can help predict tumor shrinkage after therapy and reduce the amount of additional radiotherapy or chemotherapy treatment the participant may need. This study will also examine ways to reduce overall side effects of treatment using robotic surgery, chemotherapy and radiotherapy, or radiotherapy alone.
Sites
- University of Chicago Medical CenterChicago, Illinois, United States